⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 1, 2025

Table S4 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites

Tongtong Wu Zhicong Yang Sufan Tang Hongmei Yuan Yang Liu Haiyang Li Nan Liu Zhanwen Huang Yue Chen Zhijun Zhou

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study focuses on the biodistribution of radioactive ligands in the U87MG tumor model.
Data shows organ biodistribution of [177Lu]Lu-DOTA-LP expressed as %ID/g tissue.
Analysis included 3 to 5 samples, providing robust mean and standard deviation results.
Targeting fibroblasts with albumin-binding sites indicates potential for improving cancer therapy methods.

Implication

Research demonstrates organ biodistribution of 177Lu-DOTA-LP in U87MG tumor model, highlighting its potential in targeting fibroblasts.

Abstract

Table S4.Organ biodistribution of [177Lu]Lu-DOTA-LP in U87MG tumor model as %ID/g tissue. Data are expressed as mean ± SD (n = 3–5).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0289 https://doi.org/10.1158/1535-7163.29759905

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S5 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
2Table S6 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
3Table S7 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
4Table S3 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
5Figure S13 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025